Home

John Celebi

CIK 1843539 · PRESIDENT AND CEO · last filed 2025-02-26

John Celebi is a PRESIDENT AND CEO who has filed 11 SEC Form 4 insider transactions across 1 company since 2021. The most recent filing, for SNSE, was dated Feb 24, 2026. Across all open-market trades the lifetime net is +$425, making them a net buyer over the disclosed history.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

1

Total Filings

11

Lifetime Open-Market Net

$425

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Sensei Biotherapeutics, Inc. (SNSE) Delisted PRESIDENT AND CEO 5,293 $13.85 $73.3K $425 10 2025-02-26

Recent Filings

11 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-02-24 Sensei Biotherapeutics, Inc. (SNSE) Delisted Notice (144) −3,374 -$116.4K EDGAR
2025-02-26 Sensei Biotherapeutics, Inc. (SNSE) Delisted Tax (F) −5,558 -$2.6K EDGAR
2025-02-14 Sensei Biotherapeutics, Inc. (SNSE) Delisted Grant (A) — $0 EDGAR
2024-12-23 Sensei Biotherapeutics, Inc. (SNSE) Delisted Grant (A) — $0 EDGAR
2024-02-16 Sensei Biotherapeutics, Inc. (SNSE) Delisted Mixed −5,891 -$4.7K EDGAR
2023-09-13 Sensei Biotherapeutics, Inc. (SNSE) Delisted Buy (P) +500 $425 EDGAR
2023-09-11 Sensei Biotherapeutics, Inc. (SNSE) Delisted Tax (F) −20,492 -$30.7K EDGAR
2023-03-29 Sensei Biotherapeutics, Inc. (SNSE) Delisted Grant (A) +73,193 $0 EDGAR
2023-02-17 Sensei Biotherapeutics, Inc. (SNSE) Delisted Grant (A) +73,193 $0 EDGAR
2022-02-17 Sensei Biotherapeutics, Inc. (SNSE) Delisted Grant (A) +53,900 $0 EDGAR
Showing 1–10 of 11
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.